デフォルト表紙
市場調査レポート
商品コード
1676153

経腸栄養製剤の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Enteral Feeding Formulas Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033


出版日
ページ情報
英文 159 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
経腸栄養製剤の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 159 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経腸栄養製剤の世界市場規模は、2024年の68億8,000万米ドルから2033年には117億9,000万米ドルに成長し、2026~2033年の予測期間中に6.17%の堅調な年間平均成長率(CAGR)を示すと予測されます。

経腸栄養製剤市場は、嚥下障害や栄養不良の患者に対する栄養サポートの需要が高まるにつれて大きな成長を遂げています。経腸栄養製剤は、慢性疾患、神経障害、手術後の回復など、経口で食物を摂取できない患者に必要な栄養素を供給するために特別に設計されています。がん、脳卒中、胃腸障害などの疾患の有病率の上昇が、経腸栄養製剤の需要を押し上げています。医療プロバイダーが患者に十分な栄養を確保しようとしているため、経腸栄養製剤市場は繁栄が見込まれています。

経腸栄養製剤市場の将来を形作る上で、技術の進歩が重要な役割を果たしています。特定の病状に合わせた特殊製剤の開発など、製剤科学の革新が経腸栄養の効果を高めています。さらに、すぐに使えるものや持ち運び可能なものなど、包装や送達システムの先進化により、経腸栄養製品の利便性と入手しやすさが向上しています。メーカーが研究開発への投資を続けていることから、経腸栄養製剤市場は、病院、長期療養施設、在宅医療など、さまざまな医療環境での採用が増加するとみられます。

さらに、患者中心のケアと個別化された栄養を重視する傾向が強まっていることも、経腸栄養製剤市場の成長軌道に影響を与えています。患者や介護者が栄養ニーズについて知識を深めるにつれ、個人の嗜好や食事制限に対応した経腸栄養製剤に対する需要が高まっています。この動向は、患者の満足度を高め、哺乳計画の遵守を強化するカスタマイズ型ソリューションを開発するために、メーカー、医療プロバイダー、栄養士間の協力を促進しています。市場が進化を続ける中、技術、個別化、患者エンゲージメントの統合が成功の重要な促進要因となると考えられます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要:市場概要:定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因:市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析:製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢:市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測:過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析:地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会:現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 経腸栄養製剤産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 経腸栄養製剤の世界市場分析:製品タイプ別

  • 製品タイプ別概要
  • 製品タイプ別過去・予測データ分析
  • 標準製剤
  • 疾患特異的ミルク
  • 混合製剤

第6章 経腸栄養製剤の世界市場分析:ステージ別

  • ステージ別概要
  • ステージ別過去・予測データ分析
  • 成人
  • 小児

第7章 経腸栄養製剤の世界市場分析:形態別

  • 形態別概要
  • 形態別過去・予測データ分析
  • 液体
  • 粉末

第8章 経腸栄養製剤の世界市場分析:エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 病院
  • 在宅介護
  • 長期介護施設

第9章 経腸栄養製剤の世界市場分析:流通チャネル別

  • 流通チャネル別概要
  • 流通チャネル別過去・予測データ分析
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 経腸栄養製剤の世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 経腸栄養製剤企業の競合情勢

  • 経腸栄養製剤市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品発売
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Abbott Laboratories
  • NestleHealth Science
  • Danone S.A.
  • Fresenius Kabi AG
  • Mead Johnson Nutrition Company
  • Meiji Holdings Co. Ltd.
  • B. Braun Melsungen AG
  • Hormel Foods Corporation
  • Victus Inc.
  • Nutritional Medicinals LLC
  • Kate Farms
  • Nutricia Advanced Medical Nutrition
  • Medline Industries Inc.
  • Vitasoy International Holdings Limited
  • Nutritional Resources Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Standard Formulas Market Sales By Geography (USD MN)
  • Disease-Specific Formulas Market Sales By Geography (USD MN)
  • Blenderized Formulas Market Sales By Geography (USD MN)
  • Analysis By Stage (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Analysis By Form (USD MN)
  • Liquid Market Sales By Geography (USD MN)
  • Powder Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Home Care Market Sales By Geography (USD MN)
  • Long-Term Care Facilities Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Enteral Feeding Formulas Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Enteral Feeding Formulas Report
  • Market Research Process
  • Market Research Methodology
  • Global Enteral Feeding Formulas Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Stage
  • Market Attractiveness Analysis By Form
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Standard Formulas Market Sales By Geography (USD MN)
  • Disease-Specific Formulas Market Sales By Geography (USD MN)
  • Blenderized Formulas Market Sales By Geography (USD MN)
  • Global Market Analysis By Stage (USD MN)
  • Adult Market Sales By Geography (USD MN)
  • Pediatric Market Sales By Geography (USD MN)
  • Global Market Analysis By Form (USD MN)
  • Liquid Market Sales By Geography (USD MN)
  • Powder Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Home Care Market Sales By Geography (USD MN)
  • Long-Term Care Facilities Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11219148

Global Enteral Feeding Formulas Market size is anticipated to grow from USD 6.88 Billion in 2024 to USD 11.79 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.17% during the forecast period of 2026 to 2033.

The Enteral Feeding Formulas Market is experiencing significant growth as the demand for nutritional support for patients with swallowing difficulties or malnutrition increases. Enteral feeding formulas are specially designed to provide essential nutrients to individuals who cannot consume food orally, including those with chronic illnesses, neurological disorders, and post-surgical recovery. The rising prevalence of conditions such as cancer, stroke, and gastrointestinal disorders is driving the demand for enteral feeding solutions. As healthcare providers seek to ensure adequate nutrition for patients, the market for enteral feeding formulas is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the enteral feeding formulas market. Innovations in formulation science, such as the development of specialized formulas tailored to specific medical conditions, are enhancing the effectiveness of enteral nutrition. Additionally, advancements in packaging and delivery systems, including ready-to-use and portable options, are improving the convenience and accessibility of enteral feeding products. As manufacturers continue to invest in research and development, the enteral feeding formulas market is likely to see increased adoption across various healthcare settings, including hospitals, long-term care facilities, and home healthcare.

Moreover, the growing emphasis on patient-centered care and personalized nutrition is influencing the enteral feeding formulas market's growth trajectory. As patients and caregivers become more informed about nutritional needs, there is a rising demand for enteral formulas that cater to individual preferences and dietary restrictions. This trend is driving collaboration between manufacturers, healthcare providers, and nutritionists to develop customized solutions that enhance patient satisfaction and adherence to feeding regimens. As the market continues to evolve, the integration of technology, personalization, and patient engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Standard Formulas
  • Disease-Specific Formulas
  • Blenderized Formulas

By Stage

  • Adult
  • Pediatric

By Form

  • Liquid
  • Powder

By End-User

  • Hospitals
  • Home Care
  • Long-Term Care Facilities

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • COMPANIES PROFILED
  • Abbott Laboratories
  • Nestle Health Science
  • Danone S.A.
  • Fresenius Kabi AG
  • Mead Johnson Nutrition Company
  • Meiji Holdings Co. Ltd.
  • B. Braun Melsungen AG
  • Hormel Foods Corporation
  • Victus Inc.
  • Nutritional Medicinals LLC
  • Kate Farms
  • Nutricia Advanced Medical Nutrition
  • Medline Industries Inc.
  • Vitasoy International Holdings Limited
  • Nutritional Resources Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ENTERAL FEEDING FORMULAS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Stage
    • 3.7.3 Market Attractiveness Analysis By Form
    • 3.7.4 Market Attractiveness Analysis By End-User
    • 3.7.5 Market Attractiveness Analysis By Distribution Channel
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Standard Formulas Historic and Forecast Sales By Regions
  • 5.4. Disease-Specific Formulas Historic and Forecast Sales By Regions
  • 5.5. Blenderized Formulas Historic and Forecast Sales By Regions

6. GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY STAGE

  • 6.1. Overview By Stage
  • 6.2. Historical and Forecast Data Analysis By Stage
  • 6.3. Adult Historic and Forecast Sales By Regions
  • 6.4. Pediatric Historic and Forecast Sales By Regions

7. GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY FORM

  • 7.1. Overview By Form
  • 7.2. Historical and Forecast Data Analysis By Form
  • 7.3. Liquid Historic and Forecast Sales By Regions
  • 7.4. Powder Historic and Forecast Sales By Regions

8. GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-User
  • 8.2. Historical and Forecast Data Analysis By End-User
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Home Care Historic and Forecast Sales By Regions
  • 8.5. Long-Term Care Facilities Historic and Forecast Sales By Regions

9. GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1. Overview By Distribution Channel
  • 9.2. Historical and Forecast Data Analysis By Distribution Channel
  • 9.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 9.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 9.5. Online Pharmacies Historic and Forecast Sales By Regions

10. GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE ENTERAL FEEDING FORMULAS COMPANIES

  • 11.1. Enteral Feeding Formulas Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF ENTERAL FEEDING FORMULAS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Abbott Laboratories
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Nestlé Health Science
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Danone S.A.
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Fresenius Kabi AG
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. Mead Johnson Nutrition Company
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Meiji Holdings Co. Ltd.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. B. Braun Melsungen AG
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Hormel Foods Corporation
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Victus Inc.
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Nutritional Medicinals LLC
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Kate Farms
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. Nutricia Advanced Medical Nutrition
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments
  • 12.15. Medline Industries Inc.
    • 12.15.1 Company Overview
    • 12.15.2 Company Revenue
    • 12.15.3 Products
    • 12.15.4 Recent Developments
  • 12.16. Vitasoy International Holdings Limited
    • 12.16.1 Company Overview
    • 12.16.2 Company Revenue
    • 12.16.3 Products
    • 12.16.4 Recent Developments
  • 12.17. Nutritional Resources Inc
    • 12.17.1 Company Overview
    • 12.17.2 Company Revenue
    • 12.17.3 Products
    • 12.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies